Récepteur couplé protéine G < Récepteur dopaminergique < Récepteur dopaminergique D1

Facettes :

List of bibliographic references indexed by Récepteur dopaminergique

Number of relevant bibliographic references: 37.
[0-20] [0 - 20][0 - 37][20-36][20-40]

Ident.	Authors (with country if any)	Title
001950 (2011)	Anne M. Landau [Danemark, Canada] ; M. Mallar Chakravarty [Danemark, Canada] ; Campbell M. Clark [Canada] ; Athanasios P. Zis [Canada] ; Doris J. Doudet [Danemark, Canada]	Electroconvulsive Therapy Alters Dopamine Signaling in the Striatum of Non-human Primates
002076 (2009)	Andrew R. Brown [Canada] ; BIN HU [Canada] ; Michael C. Antle [Canada] ; G. Campbell Teskey [Canada]	Neocortical movement representations are reduced and reorganized following bilateral intrastriatal 6-hydroxydopamine infusion and dopamine type-2 receptor antagonism
002660 (2007)	Daniel Levesque [Canada] ; Claude Rouillard [Canada]	Nur77 and retinoid X receptors : crucial factors in dopamine-related neuroadaptation
002694 (2007)	Manon Lebel [Canada] ; Pierre Robinson [Canada] ; Michel Cyr [Canada]	Canadian association of neurosciences review : The role of dopamine receptor function in neurodegenerative diseases
002903 (2006)	Pepijn Van Den Munckhof [Canada] ; Francois Gilbert [Canada] ; Michel Chamberland [Canada] ; Daniel Levesque [Canada] ; Jacques Drouin [Canada]	Striatal neuroadaptation and rescue of locomotor deficit by L-dopa in aphakia mice, a model of parkinson's disease
002D05 (2004)	M. A. Silverdale [Royaume-Uni] ; S. L. Nicholson [Royaume-Uni] ; P. Ravenscroft [Royaume-Uni] ; A. R. Crossman [Royaume-Uni] ; M. J. Millan [France] ; J. M. Brotchie [Canada]	Selective blockade of D3 dopamine receptors enhances the anti-parkinsonian properties of ropinirole and levodopa in the MPTP-lesioned primate
002D36 (2004)	Naila Ismayilova [Canada] ; Alan Crossman [Canada] ; Alexei Verkhratsky [Canada] ; Jonathan Brotchie [Canada]	Effects of adenosine A1, dopamine D1 and metabotropic glutamate 5 receptors-modulating agents on locomotion of the reserpinised rats
002E96 (2003)	W. R. Wayne Martin [Canada] ; Marguerite Wieler [Canada]	Treatment of Parkinson's disease
002F05 (2003)	Pierre J. Blanchet [États-Unis, Canada] ; Leo Verhagen Metman [États-Unis] ; Thomas N. Chase [États-Unis]	Renaissance of amantadine in the treatment of Parkinson's disease
002F40 (2003)	A. Jon Stoessl [Canada] ; Raul De La Fuente-Fernandez [Canada]	Dopamine receptors in Parkinson's disease: Imaging studies
003049 (2002)	Anette V. Nieves [Canada, États-Unis] ; Anthony E. Lang [Canada]	Treatment of excessive daytime sleepiness in patients with Parkinson's Disease with modafinil
003053 (2002)	J. Q. Lu [Canada] ; A. J. Stoessl [Canada]	Somatostatin modulates the behavioral effects of dopamine receptor activation in parkinsonian rats
003289 (2001)	Pierre J. Blanchet [Canada] ; Frédéric Calon [Canada] ; Marc Morissette [Canada] ; Martin Goulet [Canada] ; Richard Grondin [Canada] ; Daniel Levesque [Canada] ; Paul J. Bedard [Canada] ; Thérèse Di Paolo [Canada]	Regulation of dopamine receptors and motor behavior following pulsatile and continuous dopaminergic replacement strategies in the MPTP primate model
003352 (2001)	Marco Scarselli [Italie] ; Marianna Armogida [Italie] ; Carla Pardini [Italie] ; Serena Chiacchio [Italie] ; Giovanni U. Corsini [Italie]	Apomorphine: A novel effect for an old compound
003354 (2001)	Lana Depatie [Canada] ; Samarthji Lal [Canada]	Apomorphine and the dopamine hypothesis of schizophrenia: a dilemma?
003356 (2001)	Kjell Fuxe [Suède] ; Ingrid Strömberg [Suède] ; Patrizia Popoli [Italie] ; Roberto Rimondini-Giorgini [Suède] ; Maria Torvinen [Suède] ; Sven O. Ögren [Suède] ; Rafael Franco [Espagne] ; Luigi F. Agnati [Italie] ; Sergi Ferre [Suède]	Adenosine receptors and Parkinson's disease: Relevance of antagonistic adenosine and dopamine receptor interactions in the striatum
003512 (2000)	Frédéric Calon [Canada] ; Abdallah Hadj Tahar [Canada] ; Pierre J. Blanchet [Canada] ; Marc Morissette [Canada] ; Richard Grondin [Canada] ; Martin Goulet [Canada] ; Jean-Pierre Doucet [Canada] ; George S. Robertson [Canada] ; Eric Nestler [États-Unis] ; Thérèse Di Paolo [Canada] ; Paul J. Bédard [Canada]	Dopamine-receptor stimulation: biobehavioral and biochemical consequences
003560 (2000)	E. F. Field [Canada] ; I. Q. Whishaw [Canada] ; S. M. Pellis [Canada]	Sex differences in catalepsy : evidence for hormone-dependent postural mechanisms in haloperidol-treated rats
003561 (2000)	Erich Mohr [Canada] ; Tilak Mendis [Canada] ; Kathleen Hildebrand [Canada] ; Peter Paul De Deyn [Belgique]	Risperidone in the treatment of dopamine-induced psychosis in Parkinson's disease: An open pilot trial
003567 (2000)	B. J. Snow [Canada] ; F. J. G. Vingerhoets [Canada] ; J. W. Langston [États-Unis] ; J. W. Tetrud [États-Unis] ; V. Sossi [Canada] ; D. B. Calne [Canada]	Pattern of dopaminergic loss in the striatum of humans with MPTP induced parkinsonism
003570 (2000)	P. E. Radau [États-Unis, Canada, Allemagne] ; R. Linke ; P. J. Slomka ; K. Tatsch	Optimization of automated quantification of 123I-IBZM uptake in the striatum applied to parkinsonism

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/PascalFr.i -k "Récepteur dopaminergique" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/PascalFr.i  \
                -Sk "Récepteur dopaminergique" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    PascalFr.i
   |clé=    Récepteur dopaminergique
}}

---

This area was generated with Dilib version V0.6.29. Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022